{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-025596","form_type":"8-K","ticker":"ATOS","cik":"0001488039","company_name":"ATOSSA THERAPEUTICS, INC.","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.760224+00:00","generated_at":"2026-05-26T05:45:51.146167+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Atossa receives Nasdaq minimum bid price deficiency notice; compliance period through Aug 20, 2025","bullets":["Received Nasdaq deficiency notice on Feb 21, 2025 for failing to maintain $1.00 minimum bid price for 30 consecutive business days.","Compliance period ends Aug 20, 2025; possible additional 180-day extension if not compliant by then.","To regain compliance, common stock must close at $1.00+ for at least 10 consecutive business days.","Notice has no immediate effect on stock listing or trading; company monitoring and evaluating options."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-025596","json":"https://secwatch.observer/filing/0000950170-25-025596.json","markdown":"https://secwatch.observer/filing/0000950170-25-025596.md","text":"https://secwatch.observer/filing/0000950170-25-025596.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/0000950170-25-025596-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/atos-20250221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:45:51.146167+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}